Advertisement
Screener

UFP Technologies, Inc. (UFPT) Overview

UFP Technologies, Inc. (UFPT) Overview

  • 1 Apr 2026: Period ending 30 Jun 2026; Estimate (m); Actual 2.68; Beat / miss (m).
  • 1 Jan 2026: Period ending 31 Mar 2026; Estimate (m); Actual 2.24; Beat / miss (m).
  • 1 Oct 2025: Period ending 31 Dec 2025; Estimate (m); Actual 2.25; Beat / miss (m).
  • 1 Jul 2025: Period ending 30 Sept 2025; Estimate (m); Actual 2.11; Beat / miss (m).

Stock Price Chart

View more →

Blue: Split-adjusted close · Orange: Cumulative dividend-reinvested close

$176.18$202.29$232.26$266.68$306.20$351.582025-11-062026-11-06$54.48$80.19$118.03$173.72$255.69$376.342021-11-082026-11-06$21.94$38.74$68.40$120.75$213.17$376.342016-11-072026-11-06$3.36$8.64$22.20$57.02$146.49$376.342006-11-062026-11-06$0.72$2.52$8.82$30.82$107.69$376.341993-12-172026-11-06

Logarithmic scale. Both lines share the same starting value for the selected range.

Last close
$303.09
Previous close
$296.92
Change
$6.17
Change (%)
2.08%
Close date
2026-11-06
Previous close date
2026-09-29
Open
(m)
Day high
(m)
Day low
(m)
Last session volume
(m)
Last session value
(m)
Currency
USD
Price basis
split-adjusted
Volume basis
(m)

Performance

View more →

Cumulative total returns · 2026-09-29

YTD

UFPT
+33.73%
S&P 500
(m)

1 year

UFPT
+48.91%
S&P 500
(m)

3 years

UFPT
+83.91%
S&P 500
(m)

5 years

UFPT
+373.56%
S&P 500
(m)

Earnings trends

View more →

Earnings per share

USD / share · As filed

30 Jun 2026 ○ Estimate (m) ● Actual 2.68

2.032.242.452.652.8630 Jun 2025: estimate (m); actual 2.2130 Jun 2025(m)30 Sept 2025: estimate (m); actual 2.1130 Sept 2025(m)31 Dec 2025: estimate (m); actual 2.2531 Dec 2025(m)31 Mar 2026: estimate (m); actual 2.2431 Mar 2026(m)30 Jun 2026: estimate (m); actual 2.6830 Jun 2026(m)
Comparison details
Period startPeriod endingEstimateActualBeat / missReport date
1 Apr 202630 Jun 2026(m)2.68(m)(m)
1 Jan 202631 Mar 2026(m)2.24(m)(m)
1 Oct 202531 Dec 2025(m)2.25(m)(m)
1 Jul 202530 Sept 2025(m)2.11(m)(m)
1 Apr 202530 Jun 2025(m)2.21(m)(m)

31 Dec 2025 ○ Estimate (m) ● Actual 8.75

2.013.745.477.208.9331 Dec 2021: estimate (m); actual 2.0931 Dec 2021(m)31 Dec 2022: estimate (m); actual 5.4531 Dec 2022(m)31 Dec 2023: estimate (m); actual 5.8331 Dec 2023(m)31 Dec 2024: estimate (m); actual 7.5831 Dec 2024(m)31 Dec 2025: estimate (m); actual 8.7531 Dec 2025(m)
Comparison details
Period startPeriod endingEstimateActualBeat / missReport date
1 Jan 202531 Dec 2025(m)8.75(m)(m)
1 Jan 202431 Dec 2024(m)7.58(m)(m)
1 Jan 202331 Dec 2023(m)5.83(m)(m)
1 Jan 202231 Dec 2022(m)5.45(m)(m)
1 Jan 202131 Dec 2021(m)2.09(m)(m)

Revenue vs. Earnings

USD

30 Jun 2026 ■ Revenue 173.96M ■ Earnings 20.85M — Profit margin 11.99%

-20.88M9.6%51.03M10.7%122.93M11.9%194.84M13.0%30 Sept 2025: revenue 154.56M; earnings 16.38M; profit margin 10.60%30 Sept 202531 Dec 2025: revenue 148.91M; earnings 17.57M; profit margin 11.80%31 Dec 202531 Mar 2026: revenue 154.20M; earnings 17.50M; profit margin 11.35%31 Mar 202630 Jun 2026: revenue 173.96M; earnings 20.85M; profit margin 11.99%30 Jun 2026

31 Dec 2025 ■ Revenue 602.80M ■ Earnings 68.31M — Profit margin 11.33%

-72.34M5.2%176.82M7.7%425.98M10.2%675.13M12.7%31 Dec 2017: revenue 147.84M; earnings 9.21M; profit margin 6.23%31 Dec 201731 Dec 2023: revenue 400.07M; earnings 44.92M; profit margin 11.23%31 Dec 202331 Dec 2024: revenue 504.42M; earnings 58.98M; profit margin 11.69%31 Dec 202431 Dec 2025: revenue 602.80M; earnings 68.31M; profit margin 11.33%31 Dec 2025

Analyst insights

View more →
RatingsBuyHoldSellOther ratingsLast CloseAverage TargetUpsideHigh TargetLow Target
(m)(m)(m)(m)(m)$303.09(m)(m)(m)(m)
Past 12 Months12 Month ForecastLast Close$303.09High(m)Average(m)Low(m)2025-11-062026-11-06

Recent news

View more →

(m)

YouTube videos mentioning UFPT

View more →

(m)

Statistics

View more →

Retained observations as of 2026-11-12; financial period ending 30 Jun 2026.

Forward P/E
(m)
PEG ratio · 5-year expected
(m)
Shares held by insiders
(m)
Insider transactions · change (%)
(m)
Shares held by institutions
(m)
Institutional transactions · change (%)
(m)
Diluted EPS · 12 month
(m)
EPS estimate · next quarter
(m)
EPS estimate · next year
(m)
EPS growth · current annual estimate
(m)
EPS growth · next annual estimate
(m)
EPS growth · next 5 years expected
(m)
EPS growth · past 3 years annualized
(m)
EPS growth · past 5 years annualized
(m)
EPS change · 12 months vs prior year
(m)
EPS change · latest quarter vs previous quarter
(m)
Latest earnings report date
(m)
EPS surprise · latest reported quarter
(m)
Net income · 12 month
$72.29M
Profit margin
11.45%
Return on assets · 12 month
10.98%
Named executive and board stock awards · latest fiscal year
(m)
Index membership
(m)
IPO date
(m)
Options available
(m)
Shortable
(m)
Analyst recommendation
(m)
Analyst target price
(m)
Price volatility · week
(m)
Price volatility · month
(m)
Average true range · 14 sessions
(m)
Relative strength index · 14 sessions
(m)
Relative volume
(m)
Average daily volume
112.64K
Latest session volume
(m)
Last session value
(m)
30 days ago session value
(m)
1 year ago session value
(m)
Number of trades
(m)
Total return · week
4.11%*
Total return · month
-1.04%*
Total return · quarter
12.63%*
Total return · half year
56.73%*
Total return · year to date
33.73%*
Total return · 1 year
48.91%*
Total return · 3 years
83.91%*
Total return · 5 years
373.56%*
Market cap
(m)
Book value per share · latest quarter
(m)
Price / cash · latest quarter
(m)
Enterprise value
(m)
Enterprise value / revenue
(m)
Enterprise value / EBITDA
(m)
Dividend · 12 months per share
(m)
Dividend ex-date
(m)
Next dividend ex-date
(m)
Next dividend amount per share
(m)
Dividend growth · 3 years annualized
(m)
Dividend growth · 5 years annualized
(m)
Revenue · 12 month
$631.64M
Revenue growth · past 3 years annualized
(m)
Revenue growth · past 5 years annualized
(m)
Revenue change · 12 months vs prior year
(m)
Revenue change · latest quarter vs previous quarter
(m)
Revenue surprise · latest reported quarter
(m)
Levered free cash flow · 12 month
(m)
Debt / equity · latest quarter
(m)
Long-term debt / equity · latest quarter
25.37%*
Return on equity · 12 month
(m)
Return on invested capital · 12 months
(m)
Previous close
(m)
Latest closing price
(m)
Latest session change (%)
(m)
52-week high
(m)
52-week low
(m)
Price vs 20-session moving average
(m)
Price vs 50-session moving average
(m)
Price vs 200-session moving average
(m)
Float shares
(m)
Short float (%)
(m)
Short ratio (days to cover)
(m)
Short interest (shares)
(m)

Five-year projected P/E and P/S repeat the preceding five-year EPS and revenue CAGR, holding current price and market cap constant. Hover a calculated row for its formula. Net assets = assets − debt − payables − deferred revenue − obligations due within 1 year − obligations due after 1 year.

Holders breakdown

View more →
BreakdownOwnership
(m)Shares held by all insiders
(m)Shares held by institutions
(m)Float held by institutions
(m)Institutions holding shares

Other holders

(m)

View more →

Insider holders

(m)

View more →

Top institutional holders

(m)

View more →

Top mutual fund holders

(m)

View more →

UFP Technologies, Inc. Overview

View more →

(m)

(m)

SEC CIK
914156
Industry (SIC)
3841 Surgical & Medical Instruments & Apparatus
Country of operation
United States
Business address
100 HALE STREET, NEWBURYPORT, Massachusetts, 01950, United States
Fiscal year end
1231
Phone
978-352-2200

Similar stocks

Stock NameCountryMarket CapPE Ratio
Inspire Medical Systems, Inc. (INSP)United States$1.990B9.55
NovoCure Ltd (NVCR)$1.886B-11.87
LEMAITRE VASCULAR INC (LMAT)United States$1.848B33.37
KESTRA MEDICAL TECHNOLOGIES, LTD. (KMTS)United States$1.535B-9.02
Alphatec Holdings, Inc. (ATEC)United States$1.531B-12.14
AtriCure, Inc. (ATRC)United States$3.089B
INTEGRA LIFESCIENCES HOLDINGS CORP (IART)United States$1.234B-193.02
ARTIVION, INC. (AORT)United States$1.123B-345.09
IRADIMED CORP (IRMD)United States$1.089B52.92
TANDEM DIABETES CARE INC (TNDM)United States$1.059B-16.57